= 0.44 Inventors with similar research interests:
Location History:
- Basle, DE (1992)
- Basle, CH (1991 - 2005)
- Basel, CH (1989 - 2021)
Company Filing History:
73 out of 4,942 
6 out of 19 
2 out of 68 
Years Active: 1989-2021
Title: Peter Mohr: A Collaborative Innovator in Basel
Introduction:
Peter Mohr, an inventive mind based in Basel, Switzerland, has made significant contributions to the field of pharmaceutical research and development. With an impressive portfolio of 83 patents, his work has focused on the discovery and development of novel compounds as inhibitors for HtrA1. Mohr's expertise and collaborative nature have allowed him to forge successful partnerships with renowned companies, including Hoffmann-la Roche Inc. and Arrowhead Madison, Inc. Let's delve deeper into Mohr's latest patents, his notable career highlights, and his fruitful collaborations.
Latest Patents:
Among Peter Mohr's latest patents are two groundbreaking inventions centered around difluoroketamide and trifluoromethylpropanamide derivatives as HtrA1 inhibitors. These compounds, represented by a general formula (I), hold immense potential for therapeutic applications. Mohr's patents describe a range of variations in the R group, allowing for versatility in developing compositions and methods of using the compounds. Such inventions pave the way for novel treatments and advancements in pharmaceutical sciences.
Career Highlights:
Throughout his career, Peter Mohr has established himself as a prolific inventor with a keen focus on medicinal chemistry. His tireless efforts have resulted in an impressive portfolio comprising 83 patents, showcasing his dedication to innovation. Mohr's research and development work has been instrumental in advancing pharmaceutical discoveries and improving patient care.
Collaborations:
Peter Mohr's collaborative approach has played a crucial role in his success and the advancement of his patented inventions. Notably, Mohr has worked with distinguished individuals such as Michael J Klaus and Ekkehard Weiss, forming fruitful professional partnerships. These collaborative efforts have led to significant breakthroughs in pharmaceutical research and expanded the scope of Mohr's inventions.
Conclusion:
Peter Mohr, a prominent figure in Basel's innovation landscape, has consistently pushed the boundaries of pharmaceutical research through his inventive spirit and collaborative mindset. With a remarkable portfolio of 83 patents, his latest inventions involving HtrA1 inhibitors open doors to novel therapeutic possibilities. Mohr's collaborations with esteemed companies like Hoffmann-la Roche Inc. and Arrowhead Madison, Inc., along with esteemed colleagues such as Michael J Klaus and Ekkehard Weiss, have further propelled his innovations. Peter Mohr's contributions to the field of medicinal chemistry continue to shape the future of pharmaceutical advancements, benefiting countless individuals worldwide.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.